Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ACTRN12626000068369) titled 'Boostability and safety of the single-visit rabies pre-exposure vaccination in adults' on Jan. 19.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: The University of Queensland
Condition:
Rabies
Rabies
Infection - Other infectious diseases
Intervention:
Product: Verorab(R) (Inactivated rabies virus vaccine, Sanofi-Aventis Australia).
Participants will be randomised (1:1:1:1) to one of four pre-exposure prophylaxis (PrEP) schedules, either intraderma...